{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:16:07Z","timestamp":1778087767997,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.humpath.2026.106107","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:54:28Z","timestamp":1773676468000},"page":"106107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Absence of CD38 expression in mantle cell lymphoma correlates with distinct pathological and genetic features"],"prefix":"10.1016","volume":"172","author":[{"given":"Sara","family":"Abu Mehsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fnu","family":"Monika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shidhant","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietrich Werner","family":"Idiaquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazan","family":"Al-Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hammad","family":"Tashkandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2054-5986","authenticated-orcid":false,"given":"Mingfei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106107_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1074-7613(00)80353-2","article-title":"The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer","volume":"7","author":"Shubinsky","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.humpath.2026.106107_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121527","article-title":"CD38, a receptor with multifunctional activities: from modulatory functions on regulatory cell subsets and extracellular vesicles, to a target for therapeutic strategies","volume":"8","author":"Morandi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.humpath.2026.106107_bib3","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1096\/fasebj.10.12.8903511","article-title":"Human CD38, a cell-surface protein with multiple functions","volume":"10","author":"Mehta","year":"1996","journal-title":"FASEB J"},{"key":"10.1016\/j.humpath.2026.106107_bib4","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1073\/pnas.77.3.1588","article-title":"Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage","volume":"77","author":"Reinherz","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2026.106107_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0198-8859(81)90021-5","article-title":"Comparative expression of T9, T10, and ia antigens on activated human T cell subsets","volume":"3","author":"Hercend","year":"1981","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humpath.2026.106107_bib6","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/intimm\/5.10.1259","article-title":"Phenotypic and functional heterogeneity of the IgD- B cell compartment: identification of two major tonsillar B cell subsets","volume":"5","author":"Lagresle","year":"1993","journal-title":"Int Immunol"},{"key":"10.1016\/j.humpath.2026.106107_bib7","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1073\/pnas.78.6.3848","article-title":"Expression of cell surface markers after human B lymphocyte activation","volume":"78","author":"Stashenko","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2026.106107_bib8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.4049\/jimmunol.157.4.1455","article-title":"Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression","volume":"157","author":"Lund","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2026.106107_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V98.1.181","article-title":"CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia","volume":"98","author":"Ibrahim","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106107_bib10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","article-title":"CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease","volume":"99","author":"Hamblin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106107_bib11","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106107_bib12","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management","volume":"99","author":"Rajkumar","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2026.106107_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13046-022-02421-2","article-title":"Expanding anti-CD38 immunotherapy for lymphoid malignancies","volume":"41","author":"Wang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.humpath.2026.106107_bib14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00262-021-03054-8","article-title":"Efficacy and mechanism of the anti-CD38 monoclonal antibody daratumumab against primary effusion lymphoma","volume":"71","author":"Panaampon","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.humpath.2026.106107_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2141.2010.08297.x","article-title":"Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell Non-Hodgkin lymphoma","volume":"151","author":"Mihara","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106107_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14712\/fb2020066010017","article-title":"Anti-CD38 therapy with daratumumab for relapsed\/refractory CD20-Negative diffuse large B-Cell lymphoma","volume":"66","author":"Vockova","year":"2020","journal-title":"Folia Biol (Praha)"},{"key":"10.1016\/j.humpath.2026.106107_bib17","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/bloodadvances.2023009807","article-title":"Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms","volume":"7","author":"Isabelle","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.humpath.2026.106107_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood.2024027109","article-title":"Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed\/refractory NK\/T-cell lymphoma","volume":"146","author":"Kim","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106107_bib19","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106107_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2141.2007.06526.x","article-title":"Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH","volume":"137","author":"Parry-Jones","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106107_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/cyto.b.20590","article-title":"A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma","volume":"80","author":"Medd","year":"2011","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.humpath.2026.106107_bib22","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s12032-011-0096-5","article-title":"TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage","volume":"29","author":"Dong","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.humpath.2026.106107_bib23","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/1078-0432.CCR-13-1077","article-title":"Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry","volume":"20","author":"Espinet","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2026.106107_bib24","first-page":"2209","article-title":"Leukemic presentation in nodal mantle cell lymphoma is characterized by frequent SOX11 negativity, a poor risk genomic landscape including higher TP53 alterations, and worse overall survival","volume":"110","author":"Yan","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106107_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood-2017-07-797019","article-title":"Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL network","volume":"131","author":"Aukema","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106107_bib26","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/onc.2016.502","article-title":"Census and evaluation of p53 target genes","volume":"36","author":"Fischer","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2026.106107_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/bjh.15613","article-title":"Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib","volume":"184","author":"Guarini","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106107_bib28","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood.2018889931","article-title":"PD-1\/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas","volume":"133","author":"Pascual","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106107_bib29","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood-2001-11-0066","article-title":"Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia","volume":"100","author":"Lin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106107_bib30","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.leukres.2007.10.009","article-title":"Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia","volume":"32","author":"Xu","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2026.106107_bib31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","article-title":"Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis","volume":"96","author":"Ondrejka","year":"2011","journal-title":"Haematologica"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:54:04Z","timestamp":1778086444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"alternative-id":["S0046817726000766"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106107","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absence of CD38 expression in mantle cell lymphoma correlates with distinct pathological and genetic features","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106107"}}